In a DSS-induced colitis mouse study, puerarin (Figure 1b) markedly reduced colon inflammation by inhibiting the NF-κB pathway—treated mice had significantly lower myeloperoxidase activity and reduced levels of TNF-α, IL-1β, and IL-6 in colonic tissue. Here, IL1B is linked to colitis.